ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 2c

Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress

August 9, 2021 4:02 PM EDT

Progress with FDA on evaluating tab-cel® product comparability and new robust Phase 3 ALLELE study data

Recent positive milestones with EMA provide clear path for EU Marketing Authorization Application submission in November 2021

Important new ATA188 magnetization transfer ratio (MTR) imaging biomarker data and updated clinical data to be presented at ECTRIMS in October

Company to Host Live Conference Call and Webcast Today at 4:30 p.m. EDT

SOUTH SAN FRANCISCO, Calif.--(BUSINESS... More